InvestorsHub Logo
Followers 86
Posts 7610
Boards Moderated 0
Alias Born 02/03/2018

Re: newman2021 post# 703244

Tuesday, 07/02/2024 10:37:48 AM

Tuesday, July 02, 2024 10:37:48 AM

Post# of 730065
If the answer is dcvax, when asked, "what treatment would you seek if you were diagnosed with GBM?" Then know the market will come to NWBO. That's why I sold Amrn, because no matter how fantastic, adding 25% ARR of a Cardiac Event and or Stroke, which is on top of the 25% ARR, when taking a statin alone, Vascepa should fly off pharmacy shelves, but they're not. Sales are flat. Worse, patient compliance drops off by 50% after six months. That's why CVD is called the silent killer. There's not enough fear, pain, and disability, sadly, when addressing prevention. Astonishing, but true. You need to scare the bejesus out of people to change their behavior patterns apparently. 4 years after approval, and physician awareness is flat.
GBM is as scary, debilitating, and terminal as it gets. So one way or the other, all roads lead to Rome.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News